EMCDDA launches new practical manual for decision-makers
Bibliography: International Policy Issues
Legal Regulation of drugs through a social justice lens
15 key priorities to be included in legal regulation policy that will directly impact and strengthen sustainable development and global equity (Health Poverty Action)
New report highlights public health and social risks posed by synthetic cannabinoids in Europe
Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA)
Turning the tide: Growth, visibility and impact of the civil society drug policy reform movement at the UN
This briefing paper offers a historical analysis of civil society advocacy for drug policy reform at the UN, assessing the many gains made and challenges encountered over time – and ways in which reform-oriented civil society has met, resisted, and generally overcome, these challenges (idpc)
UNODC World Drug Report 2021
Pandemic effects ramp up drug risks, as youth underestimate cannabis dangers (UNODC)
Council approves EU Drugs Action Plan 2021–2025
The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the EU Drugs Strategy, adopted in December 2020 (EMCDDA)
Quality Standards for Civil Society Involvement in Drug Policy
In this report, the EU Civil Society Forum on Drugs will provide you with guidelines on how to make the involvement of civil society in drug policy more meaningful
Latest wastewater data reveal drug-taking habits in a record 82 European cities
The 2020 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study (EMCDDA)
Failure To Fund
The continued crisis for harm reduction funding in low- and middle-income countries download (HRI)
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths
Narcotic Drugs – Estimated World Requirements for 2021
The Report of the International Narcotics Control Board for 2020
Taking stock of half a decade of drug policy – An evaluation of UNGASS implementation
This report aims to take stock of progress made on the implementation of the operational recommendations included in the UNGASS Outcome Document (idpc)
Methamphetamine developments in South Asia: the situation in Iran and the implications for the EU and its neighbours — EU4MD special report
The report is the result of research conducted under the EU4Monitoring Drugs (EU4MD) project, funded by the European Commission (EMCDDA)
What is drug policy evaluation and why is it important?
Timeline of EU drug strategies and plans and their evaluation (EMCDDA)
Edging forward: How the UN’s language on drugs has advanced since 1990 (Version 2
this paper explores a selection of key themes by analysing the consensus based language agreed by UN member states (IDPC)
Death Penalty For Drug Offences: Global Overview 2020
This report, our tenth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international law (Harm Reduction International)
International Narcotics Control Board
2020 Special Report: Celebrating 60 Years of the Single Convention on Narcotic Drugs of 1961 and 50 Years of the Convention on Psychotropic Substances of 1971
Single programming document 2021–2023
The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025
GDS 2020 Key Findings
Download report
Western Hemisphere Drug Policy Commission report
The Western Hemisphere Drug Policy Commission is an independent, bipartisan entity with a two-fold mission: evaluate a range of US counternarcotics programs in the Americas and then make recommendations to improve them
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 14
- Next Page »
